Présentation de l'entreprise
Trupanion, Inc. operates as a provider of veterinary medical insurance for companion animals, specifically cats and dogs, utilizing a subscription-based business model across the United States, Canada, Continental Europe, and Australia. The company functions within the broader Financial Services sector, specifically classified under the Insurance - Property & Casualty industry, which signifies its role in risk pooling and premium collection rather than traditional lending or securities trading. On a significant scale, the entity manages a market capitalization of $1.11 billion while generating annual revenue of $1.44 billion and employing 1.121 people. These valuation and revenue figures indicate that the company has established a substantial market presence with a balance sheet large enough to support complex actuarial operations and international expansion. The scale of operations, evidenced by the $1.44 billion in revenue, suggests a mature business model capable of withstanding market fluctuations, while the $1.11 billion market cap reflects investor confidence in its recurring revenue streams derived from pet owners and veterinarians.
Santé financière
The company reported a trailing twelve-month revenue of $1.44 billion with a net income of $19.43 million and an EBITDA of $31.11 million. The substantial gap between the $1.44 billion in revenue and the $19.43 million in net income reveals a cost structure where operating expenses, including claims payments and administrative costs, absorb the majority of top-line growth before reaching the bottom line. Free cash flow stands at -$23.275 million, indicating that the company is currently burning cash, which limits immediate financial flexibility and suggests capital is being deployed toward growth initiatives or operational restructuring. The gross margin is 22.6%, operating margin is 2.2%, and profit margin is 1.4%; these levels indicate that the company operates on thin spreads where efficiency in claims management is critical to maintaining profitability. Total cash holdings of $370.73 million significantly exceed total debt of $125.95 million, suggesting a balance sheet that is conservative regarding leverage despite the negative free cash flow position. The debt-to-equity ratio of 32.80% further supports the view that the company is not highly leveraged, providing a buffer against economic downturns. Liquidity is robust as indicated by a current ratio of 1.67, meaning the company possesses sufficient current assets to cover its short-term liabilities without difficulty. Finally, the return on equity is 5.5% and the return on assets is 1.1%, metrics that reveal management effectiveness in generating returns relative to the capital invested and the asset base utilized, though the low ROA reflects the capital-intensive nature of the insurance underwriting business.
Évaluation de la valorisation
The trailing twelve-month P/E ratio is 57.04, while the forward P/E is 6.04, a stark difference implying that the market currently prices in a massive expansion of future earnings or expects a significant correction in current valuations. The price-to-book ratio stands at 2.90, indicating that the market values the company at nearly three times its net asset book value, which suggests a premium assigned to the company's intangible assets, brand, and future growth potential. Alternative valuation metrics such as the price-to-sales ratio of 0.77 and an EV/EBITDA of 27.97 suggest that the stock is trading at a moderate multiple of sales but at a high multiple of earnings before interest, taxes, depreciation, and amortization, highlighting the tension between revenue generation and current profitability. The 52-week high is $57.88 and the 52-week low is $24.32, placing the current trading environment within a wide historical range that reflects high volatility and significant price discovery. The beta value of 1.66 indicates that the stock price is expected to be 66% more volatile than the broader market, signaling higher risk for investors seeking stability.
Growth & Income
Revenue growth year-over-year is 11.7%, while earnings growth year-over-year is 235.1%, demonstrating that earnings are expanding at a rate vastly faster than revenue, which often occurs during periods of cost optimization or margin expansion. The company does not pay a dividend, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning all net income is retained within the company to fund operations and growth rather than being distributed to shareholders. Consequently, the company reinvests its earnings directly back into the business to fuel the 11.7% revenue expansion and support the massive 235.1% earnings surge observed recently. The overall growth and income profile is characterized by aggressive earnings expansion with no current income distribution, relying entirely on capital appreciation and future cash flow generation to deliver value to equity holders.